From: 39th International Symposium on Intensive Care and Emergency Medicine
Variables | Model 1 AKI development | P-value | Model 2 AKI nonrecovery 1,2 | P-value |
---|---|---|---|---|
OR (95% CI) | OR (95% CI) | |||
BMI | 1.06(1.04,1.07) | <0.01 | Â | Â |
SOFA score before AKI | Â | Â | 1.00(0.91-1.09) | 0.97 |
SOFA score after AKI | Â | Â | 1.11(1.00-1.24) | 0.06 |
Lowest MAP after AKI | Â | Â | 0.99(0.96-1.02) | 0.99 |
CKD in AKI development model | 1.81(1.34,2.45) | <0.01 | Â | Â |
CKD in before AKI model | Â | Â | 1.98(1.08-3.64) | 0.03 |
CKD in after AKI model | Â | Â | 4.39(1.36-5.75) | 0.01 |
Mechanical ventilation before AKI | Â | Â | 2.30(1.20-4.44) | 0.01 |
Mechanical ventilation after AKI | Â | Â | 1.63(2.07-9.30) | <0.01 |
Norepinephrine use before AKI | Â | Â | 1.44(0.73-2.83) | 0.29 |
Norepinephrine use after AKI | Â | Â | 1.67(0.61-4.56) | 0.32 |
Diuretic use before AKI | Â | Â | 1.90(1.18-3.06) | 0.01 |